Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mesa LaboratoriesMLAB -3.42%77 Equity-to-Asset is 0.44 as of Mar. 2026, which is 21% below its 10-year median of 0.56. GuruFocus rates MLAB with a GF Score™ of 77/100 and a GF Value™ of $116.40 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 2,500 Hardware companies, Mesa Laboratories ranks worse than 68.4% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Mesa Laboratories's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $186.2 Mil. Mesa Laboratories's Total Assets for the quarter that ended in Mar. 2026 was $427.7 Mil.
Therefore, Mesa Laboratories's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.44.
The historical rank and industry rank for Mesa Laboratories's Equity-to-Asset or its related term are showing as below:
MLAB'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.33 Med: 0.56 Max: 0.71
Current: 0.44
During the past 13 years, the highest Equity to Asset Ratio of Mesa Laboratories was 0.71. The lowest was 0.33. And the median was 0.56.
MLAB's Equity-to-Asset is ranked worse than 68.4% of 2500
companies
in the Hardware industry
Industry Median: 0.57
vs MLAB: 0.44
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Mesa Laboratories Equity-to-Asset Related Terms
Mesa Laboratories Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Mesa Laboratories's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MLAB vs AERG, USBC, MVIS: Equity-to-Asset Comparison
For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mesa Laboratories Equity-to-Asset vs Hardware Industry
For the Hardware industry and Technology sector, Mesa Laboratories's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Mesa Laboratories's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Mesa Laboratories's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mesa Laboratories (MLAB) has a Equity-to-Asset of 0.44 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Mesa Laboratories and its competitors. This is 21% below median its historical median of 0.56. Over the past decade, Mesa Laboratories' Equity-to-Asset has ranged from 0.33 to 0.71. According to the industry distribution chart, Mesa Laboratories ranks #1710 out of 2500 companies in the Hardware industry, placing it in the top 68.4%.
Is Mesa Laboratories' Equity-to-Asset too high?
Mesa Laboratories' current Equity-to-Asset of 0.44 is 21% below median its 10-year median of 0.56. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 0.71. The Hardware industry median Equity-to-Asset is 0.57. Mesa Laboratories' value of 0.44 is 22.8% below this industry median. Based on the distribution chart, Mesa Laboratories ranks #1710 out of 2500 companies in the Hardware industry, which is below the industry midpoint. Overall, Mesa Laboratories has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' Equity-to-Asset compare to AERG and USBC?
According to the Hardware industry distribution chart, Mesa Laboratories ranks #1710 out of 2500 companies for Equity-to-Asset. This places Mesa Laboratories in the lower half of its industry. The industry median Equity-to-Asset is 0.57. Mesa Laboratories' value of 0.44 is 22.8% below this benchmark. Historically, Mesa Laboratories' own Equity-to-Asset has ranged from 0.33 to 0.71 over the past decade. While the company's 10-year median is 0.56 vs. the industry median of 0.57, Mesa Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Hardware company?
The median Equity-to-Asset among Hardware companies is 0.57, based on 2,500 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mesa Laboratories's current Equity-to-Asset of 0.44 is 22.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Mesa Laboratories and its competitors. For the Hardware industry, the median Equity-to-Asset is 0.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mesa Laboratories's current Equity-to-Asset is 0.44, which is 21% below median its own 10-year median of 0.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is $116.40, compared to a current price of $97.72 — trading 16% below its estimated fair value. The current Equity-to-Asset is 0.44, which is 21% below median its 10-year median of 0.56 and 22.8% below the Hardware industry median of 0.57. Mesa Laboratories' overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current Equity-to-Asset is 0.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mesa Laboratories (MLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued.
The current stock price of $97.72 is trading 16% below its estimated GF Value™ of $116.40.
GuruFocus considers Mesa Laboratories to be Modestly Undervalued.
Key valuation signals for MLAB:
Equity-to-Asset: 0.44 (21% below median its 10-year median of 0.56)
GF Value™: $116.40 vs. price of $97.72 (16% below fair value)
Industry Position: 22.8% below the Hardware median (#1710 of 2500)
No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
77GF Score
Get the complete analysis for MLAB
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLAB has been successfully added to your 
